Angiotensin Neprilysin Inhibition for Patients With Heart Failure What If Sacubitril/Valsartan Were a Treatment for Cancer?

被引：18
|
作者：
Packer, Milton [1 ]
机构：
[1] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, 621 N Hall St, Dallas, TX 75226 USA
来源：
JAMA CARDIOLOGY | 2016年 / 1卷 / 09期
关键词：
ENALAPRIL;
D O I：
10.1001/jamacardio.2016.3053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 972
页数：2
相关论文
共 50 条
  • [21] The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond
    Kazuomi Kario
    Current Cardiology Reports, 2018, 20
  • [22] The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond
    Kario, Kazuomi
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (01)
  • [23] Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure
    Vader, Justin M.
    Givertz, Michael M.
    Starling, Randall C.
    McNulty, Steven E.
    Anstrom, Kevin J.
    Desvigne-Nickens, Patrice
    Hernandez, Adrian F.
    Braunwald, Eugene
    Mann, Douglas L.
    JACC-HEART FAILURE, 2022, 10 (07) : 449 - 456
  • [24] Early Implementation of Sacubitril/Valsartan for Patients With Heart Failure
    Wilcox, Jane E.
    JAMA CARDIOLOGY, 2020, 5 (02) : 207 - 208
  • [25] Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
    Morrow, David A.
    Velazquez, Eric J.
    Desai, Akshay S.
    Devore, Adam D.
    Lepage, Serge
    Park, Jeong-Gun
    Sharma, Kavita
    Solomon, Scott D.
    Starling, Randall C.
    Ward, Jonathan H.
    Williamson, Kristin M.
    Zieroth, Shelley
    Hernandez, Adrian F.
    Mentz, Robert J.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (12) : 1132 - 1132
  • [26] Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure
    Sangaralingham, Lindsey R.
    Sangaralingham, S. Jeson
    Shah, Nilay D.
    Yao, Xiaoxi
    Dunlay, Shannon M.
    CIRCULATION-HEART FAILURE, 2018, 11 (02)
  • [27] The safety of sacubitril/valsartan in the geriatric heart failure patients
    Alharthi, M. Maha
    Bakhsh, A.
    Alawwad, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 138 - 138
  • [28] Efficacy and Safety of Sacubitril/valsartan in Patients with Heart Failure
    Alhabeeb, Waleed
    Al Ayoubi, Fakhr
    Hayajneh, Ahmad
    Elshaer, Fayez
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2020, 9 (04): : 11 - 18
  • [29] Sacubitril-valsartan in heart failure and multimorbidity patients
    Rodil Fraile, Raquel
    Malafarina, Vincenzo
    Tiberio Lopez, Gregorio
    ESC HEART FAILURE, 2018, 5 (05): : 957 - 960
  • [30] Sacubitril/valsartan and circulating neprilysin hypothesis in patients with HFpEF
    Santiago-Vacas, E.
    Codina, P.
    Domingo, M.
    De Antonio, M.
    Zamora, E.
    Santesmases, J.
    Julian, M. T.
    Diez-Quevedo, C.
    Troya, M., I
    Boldo, M.
    Altimir, S.
    Nunez, J.
    Gonzalez, B.
    Lupon, J.
    Bayes-Genis, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 860 - 860
12345